Yana Kipnis
Lawyers

Advises clients on IP, technology and commercial matters, including M&A, licensing, sponsorships, collaborations and other strategic transactions.
Yana advises clients on complex commercial transactions, as well as the IP and technology aspects of a wide range of corporate transactions, including carve-outs, acquisitions, joint ventures and spinoffs. She has extensive experience drafting and negotiating bespoke commercial arrangements, including with respect to licensing, sponsorships and branding, manufacturing, supply and distribution, outsourcing, services agreements and other strategic collaborations.
Experience
Recent Work
- Airbus acquisition of certain assets and sites from Spirit AeroSystems
- Nova Biomedical $2.2 billion acquisition by Advanced Instruments
- GH Research $150 million follow-on offering
- Airbus potential acquisition of certain Spirit AeroSystems activities
- Roche $295 million acquisition of LumiraDx's point of care technology platform
- GSK exclusive license agreement for HS-20089 with Hansoh Pharma
- Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
- Marvell Technology $1 billion senior notes offering
- Intuit $4 billion notes offering
- PracticeTek merger with Integrated Practice Solutions and related financing
- Immedica Pharma acquisition of pegzilarginase assets from Aeglea
- Ocado Group acquisition of 6 River Systems
- Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
- Natura $2.525 billion sale of Aesop to L’Oréal
- SSW Partners $1.525 billion sale of Veoneer Active Safety business to Magna
- Seagate HDD Cayman $750 million exchange offers
Education
J.D., New York University School of Law
- magna cum laude
- Order of the Coif
B.B.A., Marketing, CUNY Macaulay Honors College at Baruch College
- summa cum laude
Qualifications and admissions
- State of New York